tiprankstipranks
NGM Biopharmaceuticals Inc (NGM)
NASDAQ:NGM
Holding NGM?
Track your performance easily

NGM Biopharmaceuticals (NGM) Income Statement

330 Followers

NGM Biopharmaceuticals Income Statement

Last quarter (Q3 2023), NGM Biopharmaceuticals's total revenue was $582.00K, a decrease of -92.64% from the same quarter last year. In Q3, NGM Biopharmaceuticals's net income was $-28.80M. See NGM Biopharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 22.35M$ 55.30M$ 77.90M$ 87.37M$ 103.54M$ 108.67M
Cost of Revenue
------
Gross Profit
$ 22.35M$ 55.30M$ 77.90M---
Operating Expense
$ 77.65M$ 221.58M$ -198.58M$ 191.20M$ 152.88M$ 112.98M
Operating Income
$ -160.18M$ -166.25M$ -120.68M$ -103.83M$ -49.34M$ -4.31M
Net Non Operating Interest Income Expense
$ 9.31M$ 3.71M$ 420.00K$ 1.94M$ 6.69M$ 3.62M
Other Income Expense
$ 356.00K$ 132.00K$ 60.00K$ -593.00K$ -147.00K$ 199.00K
Pretax Income
$ -151.22M$ -162.70M$ -120.32M$ -102.49M$ -42.80M$ -493.00K
Tax Provision
----$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -151.22M$ -162.70M$ -120.32M$ -102.49M$ -42.80M$ -493.00K
Basic EPS
$ -1.82$ -2.03$ -1.56$ -1.50$ -0.85$ >-0.01
Diluted EPS
$ -1.82$ -2.03$ -1.56$ -1.50$ -0.85$ >-0.01
Basic Average Shares
$ 327.12M$ 79.95M$ 77.08M$ 68.48M$ 50.30M$ 64.99M
Diluted Average Shares
$ 327.12M$ 79.95M$ 77.08M$ 68.48M$ 50.30M$ 64.99M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 77.65M$ 221.58M$ -198.58M$ 191.20M$ 152.88M$ 112.98M
Net Income From Continuing And Discontinued Operation
$ -151.18M$ -162.67M$ -120.32M$ -102.49M$ -42.80M$ -493.00K
Normalized Income
$ -47.98M$ -128.53M-$ -102.49M$ -42.80M$ -493.00K
Interest Expense
------
EBIT
$ -153.25M$ -162.70M$ -120.32M$ -103.83M$ -49.34M$ -4.31M
EBITDA
$ -154.21M$ -156.68M$ -108.89M$ -97.28M$ -41.73M$ 2.91M
Currency in USD

NGM Biopharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis